Gsk1104252a structure
|
Common Name | Gsk1104252a | ||
|---|---|---|---|---|
| CAS Number | 1001397-20-1 | Molecular Weight | 478.53700 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H27FN4O5S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Gsk1104252aGSK1104252A is a potent and selective GPR119 agonist. GSK1104252A can be used for type 2 diabetes research[1]. |
| Name | GSK1104252A |
|---|---|
| Synonym | More Synonyms |
| Description | GSK1104252A is a potent and selective GPR119 agonist. GSK1104252A can be used for type 2 diabetes research[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C22H27FN4O5S |
|---|---|
| Molecular Weight | 478.53700 |
| Exact Mass | 478.16900 |
| PSA | 110.31000 |
| LogP | 4.18530 |
| 1-methylethyl 4-({7-[2-fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)-1 -piperidinecarboxylate |